RET-IN-10 is a potent inhibitor of RET, with RET loss-of-function mutations linked to congenital megacolon and gain-of-function mutations associated with various human tumors. RET-IN-10 has demonstrated research potential in cancer diseases.
Molekulargewicht:
536.65
CAS Nummer:
[2662622-44-6]
Formel:
C29H28N8OS
Target-Kategorie:
Others|||c-RET
T63782
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten